Insights From KOLs Attending Advisory Boards

Insights from KOLs who attend advisory board meetings organized by different pharma companies. An analysis of responses to our questionnaire allowed us to take a closer look at the disadvantages of face-to-face advisory boards and also to learn about KOLs preferences related to the meeting format.

×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure